Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trialDavid Marín, Katayoun Rezvani, May Daher et al.|Nature Medicine|2024Cited by 452
Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non–small cell lung cancerCarolyn E. Reed, Valerie W. Rusch, David H. Harpole et al.|Journal of Thoracic and Cardiovascular Surgery|2003Cited by 301